Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
510 SO-C101, a high-affinity IL-15Rbg agonist, induces safe and potent anti-tumor immune activities in patients with solid tumors and supports further clinical investigations
Compose a Response to This Article
Other responses
No responses have been published for this article.